发明名称 |
PYRIMIDINE DERIVATIVE |
摘要 |
A pyrimidine derivative simultaneously having 5-HT1A agonistic activity and 5- HT3 antagonistic activity and being useful for therapy, treatment, etc. for IBS and other diseases, represented by the formula: (I) wherein, the ring A is a carbocyclic group or heterocyclic group, X1 is a hydrogen atom, lower alky l, amino, etc., X2 is a hydrogen atom or lower alkyl, Y is a direct bond, or sulfur atom or nitrogen atom, n is an integer of 0 to 4, and Ar is a group o f the formula: or a salt of the pyrimidine derivative. Further, there is provided a method of treating IBS characterized in that 5-HT1A agonistic activity and 5-HT3 antagonistic activity are simultaneously exerted cooperatively in vivo by administering a 5-HT3 antagonist exhibiting an agonistic activity to 5-HT1A or by administering simultaneously, or in sequence, or at an interval a 5-HT1A agonist and a 5-HT3 antagonist.
|
申请公布号 |
CA2557541(A1) |
申请公布日期 |
2005.09.09 |
申请号 |
CA20052557541 |
申请日期 |
2005.02.25 |
申请人 |
ASKA PHARMACEUTICAL CO., LTD. |
发明人 |
TAMAOKI, SATORU;SATO, MICHITAKA;MATSUI, TERUAKI;ASAGARASU, AKIRA;HAYASHI, HIROYUKI;ARAKI, SEI-ICHI;YAMAMOTO, YOSHIKO;YAMAMOTO, NORIO;OGAWA, CHISATO;YAMAUCHI, YUKINAO;TAKAHASHI, NOBUYUKI |
分类号 |
C07D401/12;A61K31/496;A61K31/4985;A61K31/517;A61K31/519;A61K31/5395;A61K45/00;A61K45/06;A61P1/00;A61P1/04;A61P3/04;A61P7/00;A61P9/10;A61P9/12;A61P11/00;A61P11/14;A61P13/00;A61P13/02;A61P13/08;A61P15/00;A61P17/02;A61P19/00;A61P19/02;A61P21/00;A61P25/00;A61P25/06;A61P25/14;A61P25/16;A61P25/18;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P25/30;A61P25/32;A61P25/34;A61P27/02;A61P27/06;A61P29/00;A61P35/00;A61P37/02;A61P43/00;C07D401/14;C07D413/14;C07D417/12;C07D417/14;C07D471/04;C07D487/04;C07D491/147;C07D495/04;C07D495/14;C07D498/04;C07D498/14;C07D519/00 |
主分类号 |
C07D401/12 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|